Home » Newsletters » BioWorld Science

BioWorld Science

April 9, 2014

View Archived Issues

Discovery and characterization of a novel class of Gram-positive antibacterial compounds

U.S. researchers patent new lentiviral vectors for stem cell gene therapy

Idenix Pharmaceuticals reports data for nucleotide prodrug development program

Bristol-Myers Squibb discloses novel fibronectin domain-based fusion proteins

Novel anti-IAPP MAbs divulged by Neurimmune Holding

UCB and Weill Cornell Medical College establish strategic research alliance

Ventana Medical Systems signs companion diagnostic agreement with Genmab

Novartis presents results from phase III studies of secukinumab

Pfizer gains access to IntegraGen's molecular signature for hepatocellular carcinoma

ValiRx establishes joint venture with Tangent Reprofiling

NLRP3 inflammasome inhibitor efficacious in model of ischemia-reperfusion injury

TetraLogic Pharmaceuticals to acquire Shape Pharmaceuticals

Two vemurafenib prodrugs developed with improved bioavailability

Ledipasvir/sofosbuvir combination gets FDA priority review

AbbVie designs new 5-HT2C receptor agonists

Novel tricyclic antibacterials presented by the LLNL and Cubist Pharmaceuticals

AEM-28 enters phase I/II trial in refractory hypercholesterolemia

TRV-130 begins phase II for acute postoperative pain after bunionectomy

Phase I trial to examine teprotumumab for new indication of diabetic macular edema

Phase I data on LY-2874455 shows safety and a favorable pharmacokinetic profile

Ambit Biosciences begins phase III QUANTUM-R trial

Kadmon Corporation initiates phase II study of KD-025 for psoriasis

Oncolytics Biotech reports additional data from Reolysin trial in head and neck cancer

RaQualia expands joint research agreement with Asahi Kasei Pharma

Thomson Reuters and Children's Tumor Foundation collaborate on neurofibromatosis pathway maps

Genentech presents new MEK inhibitors for cancer

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...